GuiZhou SanLi Pharmaceutical Co., Ltd.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE1000040B4
CNY
12.18
0.17 (1.42%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'17
Net Sales
2,117.09
1,618.37
1,190.27
930.41
624.84
875.92
627.39
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
2,117.09
1,618.37
1,190.27
930.41
624.84
875.92
627.39
Raw Material Cost
682.97
459.64
349.43
283.49
213.76
303.29
218.18
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
302.03
0.00
0.00
0.00
0.00
0.00
16.17
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
14.65
4.16
5.30
8.36
2.23
0.23
0.00
Selling and Distribution Expenses
1,068.97
857.31
618.52
487.32
300.63
416.96
319.59
Other Expenses
-27.25
2.64
1.26
-0.07
0.34
0.33
-1.35
Total Expenditure (Excl Depreciation)
1,796.08
1,347.56
985.82
778.49
520.02
723.76
540.47
Operating Profit (PBDIT) excl Other Income
321
270.79999999999995
204.4
151.9
104.80000000000001
152.20000000000002
86.89999999999999
Other Income
14.79
62.21
12.41
28.52
5.96
3.27
17.92
Operating Profit (PBDIT)
415.27
369.23
234.73
191.58
118.89
162.97
107.65
Interest
14.65
4.16
5.30
8.36
2.23
0.23
0.00
Exceptional Items
0.15
-0.05
-0.17
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
1,434.12
1,158.73
840.83
646.92
411.08
572.63
409.21
Depreciation
76.02
37.59
17.85
11.22
8.11
7.54
4.16
Profit Before Tax
324.74
327.42
211.41
172.00
108.55
155.20
103.49
Tax
45.19
39.15
30.62
28.05
15.95
22.72
15.82
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
274.03
292.70
201.28
152.28
93.95
133.08
87.63
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
274.03
292.70
201.28
152.28
93.95
133.08
87.63
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
5.81
2.17
-9.35
-3.68
-0.00
-0.01
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
279.84
294.87
191.94
148.60
93.95
133.07
87.63
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
1,527.34
1,470.31
1,239.04
1,031.46
981.89
651.10
473.36
Earnings per share (EPS)
0.68
0.72
0.49
0.37
0.23
0.33
0.22
Diluted Earnings per share
0.68
0.72
0.49
0.37
0.23
0.33
0.22
Operating Profit Margin (Excl OI)
15.33%
16.65%
17.18%
16.32%
16.78%
17.37%
13.64%
Gross Profit Margin
18.93%
22.55%
19.26%
19.69%
18.67%
18.58%
17.16%
PAT Margin
12.94%
18.09%
16.91%
16.37%
15.04%
15.19%
13.97%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2024 is 30.81% vs 35.97% in Dec 2023

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2024 is -5.12% vs 53.67% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2024 is 30.46% vs 38.10% in Dec 2023

stock-summary

Interest

YoY Growth in year ended Dec 2024 is 247.62% vs -20.75% in Dec 2023

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2024 has fallen from Dec 2023

Compare Annual Results Of GuiZhou SanLi Pharmaceutical Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
2,117.09
0
2,117.09
Other Operating Income
0.00
0.00
0.00
Total Operating income
2,117.09
0
2,117.09
Raw Material Cost
682.97
0
682.97
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
302.03
0
302.03
Power Cost
0
0
0.00
Manufacturing Expenses
14.65
0
14.65
Selling and Distribution Expenses
1,068.97
0
1,068.97
Other Expenses
-27.25
0.00
-27.25
Total Expenditure (Excl Depreciation)
1,796.08
0
1,796.08
Operating Profit (PBDIT) excl Other Income
321.01
0.00
321.01
Other Income
14.79
0
14.79
Operating Profit (PBDIT)
415.27
0
415.27
Interest
14.65
0
14.65
Exceptional Items
0.15
0
0.15
Gross Profit (PBDT)
1,434.12
0
1,434.12
Depreciation
76.02
0
76.02
Profit Before Tax
324.74
0
324.74
Tax
45.19
0
45.19
Provisions and contingencies
0
0
0.00
Profit After Tax
274.03
0
274.03
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
274.03
0
274.03
Share in Profit of Associates
0
0
0.00
Minority Interest
5.81
0
5.81
Other related items
0.00
0.00
0.00
Consolidated Net Profit
279.84
0
279.84
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
1,527.34
0
1,527.34
Earnings per share (EPS)
0.68
0
0.68
Diluted Earnings per share
0.68
0
0.68
Operating Profit Margin (Excl OI)
15.33%
0%
0.00
15.33%
Gross Profit Margin
18.93%
0%
0.00
18.93%
PAT Margin
12.94%
0%
0.00
12.94%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 211.71 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 30.81% vs 35.97% in Dec 2023

Annual - Consolidate Net Profit
Consolidate Net Profit 27.98 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -5.12% vs 53.67% in Dec 2023

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 40.05 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 30.46% vs 38.10% in Dec 2023

Annual - Interest
Interest 1.46 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 247.62% vs -20.75% in Dec 2023

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 15.33%
in Dec 2024

Figures in %
stock-summary

YoY Growth in year ended Dec 2024 has fallen from Dec 2023